About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 7,992 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 7,992 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3501-3520 of 7,992 trials

WithdrawnErlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced RashA side effect occurring in a majority of patients taking erlotinib (Tarceva®) consists of a skin rash.NCT00803842 CompletedMolecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene LocusThe purpose of this study is to try to learn more about how small molecule kinase inhibitor medications work in treating lung cancer.NCT01300429·New York, New York TerminatedOxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung CancerThe purpose of this study is to determine the most suitable dose of Oxaliplatin that can be safely given in combination with a low fixed dose of Capecitabine and a limited volume…NCT00268151·Louisville, Kentucky CompletedA Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung CancerThis is a Phase 1/2, open-label, multicenter, sequential dose-escalation study to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of ZN-e4…NCT03446417·Duarte, California and 6 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

UnknownA Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid TumorThis is a Phase 1/2 study of GB263T in participants with advanced NSCLC and other solid tumor.NCT05332574·Saint Leonards, New South Wales and 3 others

UnknownEnsatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung CancerThe experimental design is exploratory, single-arm, multi-center, real-world research.NCT05132218·Beijing, Beijing Municipality

Active not recruitingA Phase II Clinical Trial of Ivonescimab Plus Third-generation EGFR-TKIs in Advanced Non-small Cell Lung Cancer With Gradual or Potential Progression After EGFR-TKIs TreatmentThis is a prospective, single-center, Phase II clinical study designed to explore the efficacy and safety of ivonescimab plus third-generation EGFR-TKIs in patients with advanced…NCT07669051·Jinan, Shandong

CompletedStudy to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway SignalingThis phase IB trial aims to identify anticancer activity of GSK3052230 in subjects with malignancies with abnormal dependence on FGF pathway signaling.NCT01868022·Duarte, California and 28 others

CompletedZD6474(Vandetanib) + Alimta Combo StudyThe main purpose of this trial is to look to see if adding ZD6474 (100 mg or 300mg tablets) to Alimta chemotherapy in patients with non-small cell lung cancer is safe and will…NCT00506051

UnknownApatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)The purpose of this study was to evaluate the effectiveness and safety of apatinib combined with docetaxel in NSCLC.NCT03416231·Nanchong, Sichuan

CompletedA Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung CancerThe purpose of this study is to test the safety and determine the optimal dose of a new drug, demcizumab (OMP-21M18), when given in combination with carboplatin and pemetrexed, a…NCT01189968·Herston, Queensland and 6 others

TerminatedExpression Analysis of Specific Markers in Non-small Cell Lung Cancer or MelanomaThis study intends to analyze the expression of specific sets of markers in tumor samples and in serum from patients with Non-Small Cell lung Cancer (NSCLC) or Stage III or IV…NCT00685750·Los Angeles, California and 33 others

CompletedA Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be ControlledThe purpose of this study is to learn about lorlatinib for the possible treatment of lung cancer which could not be controlled.NCT06282991·Kaohsiung City and 5 others

Active not recruitingPhase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR MutationsBDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multiple cohort study designed to evaluate the safety, pharmacokinetics (PK), optimal dosage, central nervous…NCT05256290·Birmingham, Alabama and 24 others

TerminatedAZD2014 and Weekly Paclitaxel in Squamous NSCLCOpen--label, phase 2a, multi-centre, single-arm study to assess the efficacy and safety of AZD2014 and weekly paclitaxel in patients with squamous non-small cell lung cancer…NCT02403895·Boston, Massachusetts and 6 others

UnknownBortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLCPemetrexed is an FDA-approved treatment for advanced lung cancer but the response rate is still very low.NCT00516100·Los Angeles, California and 3 others

TerminatedProton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung CancerThis research study is looking at an alternative way of delivering radiation therapy with protons.NCT01565772·Boston, Massachusetts

CompletedCamrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLCThis study is a randomized, double-blind, placebo-controlled, multi-center clinical study.NCT04768075·Beijing, Beijing Municipality and 13 others

Active not recruitingA Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerThe aim of the study is to evaluate the efficacy and safety of SKB264 in combination with pembrolizumab as firstline treatment for patients with PD-L1-positive locally advanced or…NCT06448312·Baoding and 63 others

TerminatedA Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)The clinical study will evaluate safety, tolerability and Pharmacokinetics of MK0683 in combination with carboplatin and paclitaxel in chemotherapy-naive NSCLC patients.NCT00424775

PreviousPage 176 of 400Next